BUY Kotak Mahindra Bank Ltd. — Sachin Janardan Sarvade, IDBI Capital Markets and Securities
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
6 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·15 Oct · today
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·12 Oct · 3d ago
RBI rate hike done. Now what’s ahead for bank stocks? Jefferies, other analysts weigh in
NewsEt-Markets·8 Oct · 1w ago
PNB, Kotak Mahindra Bank, other bank stocks rise up to 2% after RBI’s rate hike, Nifty Bank above 55,500
NewsEt-Markets·7 Oct · 1w ago
HSBC upgrades Kotak Mahindra Bank, raises target on CEO clarity, stronger loan growth
NewsCnbc-Tv18·7 Oct · 1w ago
HDFC Bank Nears Cheapest Post-Merger Valuation On Price-To-Book Measure
NewsNdtv-Profit·14 Oct · yesterday
RBI's Rupee Defence May Drain Banking Liquidity, Ease Currency Pressure
NewsNdtv-Profit·11 Oct · 3d ago
Four banking stocks that can move the Nifty Bank today after Q2 updates
NewsCnbc-Tv18·6 Oct · 1w ago
Kotak Mahindra Bank shares in focus after lender appoints Anup Kumar Saha as next CEO. Here’s what Nomura and Jefferies expect
NewsEt-Markets·1 Oct · 2w ago
Who Is Anup Kumar Saha: Meet The New MD And CEO Of Kotak Mahindra Bank
NewsNdtv-Profit·1 Oct · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Kotak Mahindra Bank
- BUY — Ninad Tamhanekar, Motilal Oswal13 Nov 2026 · ~2 weeks · target ₹530 · Active
- BUY — Shivangi Sarda, Motilal Oswal12 Nov 2026 · ~3 months · target ₹515 · Active
- BUY — Ajit Mishra, Religare11 Nov 2026 · ~3 months · target ₹518 · Active
- BUY — Aastha Jain, Hem Securities11 Nov 2026 · Same day · target ₹498 · Expired
- BUY — Vishvesh Chauhan, ChaseAlpha8 Nov 2026 · ~1 year · target ₹600 · Active
More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities
- BUY Gland Pharma11 Nov 2026 · ~1 year · target ₹4,415 · Active
- BUY Sansera Engineering11 Nov 2026 · ~1 year · target ₹6,265 · Active
- BUY Alkem Laboratories9 Nov 2026 · ~2 weeks · target ₹5,730 · Active
- BUY Wockhardt9 Nov 2026 · ~2 weeks · target ₹2,480 · Active
- BUY Venus Pipes & Tubes9 Nov 2026 · ~2 weeks · target ₹2,180 · Active

